The biotech world is littered with companies that failed in efforts to supply the government with products to prevent and treat bioterrorism casualties. The most recent high-stakes defeat: VaxGen, a California company that imploded after its $877.5 million contract to develop a new anthrax vaccine...
Md. Firm Vies for Anthrax Vaccine
The biotech world is littered with companies that failed in efforts to supply the government with products to prevent and treat bioterrorism casualties. The most recent high-stakes defeat: VaxGen, a California company that imploded after its $877.5 million contract to develop a new anthrax vaccine...